Severin Investments’s Pfizer PFE Stock Holding History

Severin Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$398K	Sell	16,515 -4,711	-22%	-$123K	0.3%	125
2026 Q1	$596K	Buy	21,226 +91	+0.4%	+$2.42K	0.51%	60
2025 Q4	$526K	Sell	21,135 -16,247	-43%	-$410K	0.47%	82
2025 Q3	$952K	Buy	37,382 +14,872	+66%	+$367K	0.85%	25
2025 Q2	$546K	Buy	22,510 +13,957	+163%	+$325K	0.51%	70
2025 Q1	$217K	Sell	8,553 -1,192	-12%	-$31.2K	0.22%	181
2024 Q4	$259K	Buy	+9,745	New	+$264K	0.26%	164

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Severin Investments's PFE Position: Q2 2026 in Review

Severin Investments reduced its Pfizer (PFE) stake by 22% in Q2 2026, selling an estimated $123K and leaving 16,515 shares worth $398K. The position accounts for 0.3% of the portfolio, ranked #125.

Severin Investments first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $952K in Q3 2025. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Severin Investments held 16,515 shares of Pfizer worth $398K as of Q2 2026.
Severin Investments sold 4,711 Pfizer shares in Q2 2026, an estimated $123K.
Pfizer made up 0.3% of Severin Investments's portfolio in Q2 2026, its #125 holding.
Severin Investments first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Severin Investments's Pfizer position peaked at $952K in Q3 2025.
2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.